Skip to content
Company Analysis

Embecta Corp. EMBC

A comprehensive view of key metrics, scores, and financial health for Embecta Corp.

Overview of Embecta Corp.

EMBC NMS
Healthcare Medical Instruments & Supplies Framework: Medical Devices & Diagnostics Small Cap
Embecta Corp. (EMBC), is a Small Cap company, in the Medical Instruments & Supplies industry, last closed at $6.19, about 443.8% undervalued vs fair value, -54.0% 1Y return, ranked 898/1145 in sector.
Metrics P/E 8.7× Rev Growth -3.8% ROE -13.7% Gross Margin 62.6% Div Yield 4.24%
USD 6.19
-0.96%
(Delayed)
• Vol 90d: 69.4%
52-Week Range
Market Cap
$350.72M
Enterprise Value
$1.59B
Overall Score
View breakdown
Overall
Growth
Weak
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Weak
Growth
Weak
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Weak
Completeness: 100%
Confidence: 95%
Updated: Oct 31
Top Beats

Quick Facts

Website https://www.embecta.com
HQ Parsippany, NJ
Employees 1,850
Fiscal year Sep 30

Next Events

Earnings Nov 25 Estimated

Fair Value Snapshot

Bear Base Bull
$30
$34
$38
Current: $6.19 +444% vs base

Engine Room Money Flow™

Small Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$1.1B
-3.8%%
Gross Profit
$676.8M
-7.9%%
Operating Income (GAAP)
$242.1M
45.1%%
EBITDA
$284.3M
47.5%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
62.6%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$40.7M
22.3% of Free Cash Flow

Where It Leaks

Cash Flow Health some concerns
Moderate efficiency issues detected. Review active leaks below for improvement areas.
5
Active Leaks
4/5
Improving
0
High Impact
0
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Embecta Corp.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
71
/100
Moderate
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Elite Gross Margins Gross margin quality is top-tier vs peers (score 0.78). This signals strong consumable attach-rate economics.
  • Superior Capital Returns Capital return quality is top-tier (score 0.98). High ROIC indicates the business is reinvesting at attractive rates.

Key risks

  • Elevated Leverage Leverage is elevated vs peers (score 0.17). High net debt/EBITDA limits the balance sheet's acquisition firepower.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
72
Premium

Signals, strengths and risks for Pricing Power & Consumable Moat

Premium

Signals, strengths and risks for R&D Pipeline & Capital Returns

Premium

Signals, strengths and risks for FCF Quality & Cash Conversion

Premium

Signals, strengths and risks for Commercial Execution

Premium

Signals, strengths and risks for Capital Structure & Resilience

Premium

Signals, strengths and risks for Growth Durability

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 93% Coverage
Trade-Off Triangle Visualization A ternary plot showing EMBC's balance between Growth (20.3%), Profitability (54.9%), and Safety (24.8%). Growth 20% Safety 25% Profitability 55%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

31th percentile vs peers
31
Key Signals
EPS Growth YoY 20.6% 47p Rev Growth YoY -3.8% 25p TSR 4.3% 60p Revenue CAGR 3Y -1.5% 28p EPS CAGR 3Y -25.3% 11p
Strengths
  • FCF Margin in top 20% of peers (16.9%, 89th percentile)
  • Operating Margin in top 20% of peers (22.4%, 95th percentile)
  • ROIC in top 20% of peers (22.7%, 94th percentile)
  • Operating Cash Flow Margin in top 20% of peers (17.7%, 80th percentile)
Risks
  • Growth below peer median (percentile: 31)

Profitability

84th percentile vs peers
85
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

38th percentile vs peers
38
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Embecta Corp..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$33.66
- - -
+443.8% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000